Organization
University of California-San Francisco
3 abstracts
Abstract
Clinical and analytical validation of a targeted gene expression biomarker predicting meningioma outcomes and radiotherapy responses.Org: University of California-San Francisco, University of Chicago Medical Center, Chicago, IL, University of California San Francisco, University Clinic of Heidelberg, UCSF Department of Radiation Oncology,
Abstract
Phase Ib/II study of XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) combination in metastatic melanoma refractory to prior immune checkpoint inhibitor therapy with and without CNS disease.Org: UCSF Hem/Onc Fellowship, University of California-San Francisco,
Abstract
The voice of the breast cancer survivor: Implementation of survivorship needs assessment in an integrated health system.Org: The Permanente Medical Group Consulting Services, Kaiser San Francisco, Center for Business Models in Healthcare, Glencoe, IL, Center for Business Models on Healthcare, University of California-San Francisco,